Georgia Keresty
Net worth: 578 038 $ as of 31/05/2026
Net worth: 578 038 $ as of 31/05/2026
Georgia Keresty is currently an Independent Director at Commissioning Agents, Inc. since 2018, at Intellia Therapeutics, Inc. since 2021, and at Solid Biosciences, Inc. since 2021.
Former roles include Independent Director at AspenTech Corp.
from 2019 to 2022, Director at Janssen Alzheimer Immunotherapy, The New Jersey Foundation For Aging, and Aspen Technology, Inc., Vice President-Worldwide Quantity & Compliance at Bristol Myers Squibb Co. from 1999 to 2003, Trustee at Clarkson University, Head-Manufacturing Site at Novartis Pharmaceuticals Corp.
from 1983 to 1997, Chief Operating Officer-Research & Development at Takeda Pharmaceuticals U.S.A., Inc. from 2017 to 2020, and Chief Operating Officer at Volnay Therapeutics LLC from 2023 to 2024.
Education includes graduate studies at the University of Southern California and Pace University, undergraduate studies at Clarkson University and Ramapo College of New Jersey, and an MBA and a doctorate from Rutgers State University of New Jersey.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 09/06/2026 | 41,083 ( 0.03% ) | 578 038 $ | 31/05/2026 | |
| 10/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| SOLID BIOSCIENCES INC. | Director/Board Member | 02/03/2021 |
| INTELLIA THERAPEUTICS, INC. | Director/Board Member | 09/04/2021 |
Commissioning Agents, Inc.
Commissioning Agents, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in guiding industry leaders to accelerated readiness and operational excellence | Director/Board Member | 01/01/2018 |
| Companies | Position | End |
|---|---|---|
| ASPEN TECHNOLOGY | Director/Board Member | 16/05/2022 |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Chief Operating Officer | 01/12/2020 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2003 |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/01/1997 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 15 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
AspenTech Corp.
AspenTech Corp. Packaged SoftwareTechnology Services Operates as an asset management software company | Technology Services |
Commissioning Agents, Inc.
Commissioning Agents, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in guiding industry leaders to accelerated readiness and operational excellence | Commercial Services |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarkson University
Clarkson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pace University
Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ramapo College of New Jersey
Ramapo College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Janssen Alzheimer Immunotherapy | |
Intellia Therapeutics, Inc.
Intellia Therapeutics, Inc. BiotechnologyHealth Technology Develops novel and potentially curative therapeutics | Health Technology |
Solid Biosciences, Inc.
Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
The New Jersey Foundation For Aging | |
Aspen Technology, Inc.
Aspen Technology, Inc. Packaged SoftwareTechnology Services Develops software for asset performance, monitoring management and optimization solutions | Technology Services |
Select your edition
All financial news and data tailored to specific country editions